Sub-sleeve gastrectomy achieves good diabetes control without weight loss in a non-obese diabetic rat model
详细信息 查看全文
- 作者：Dong Sun (1)
Shaozhuang Liu (1)
Guangyong Zhang (1)
Punsiri Colonne (2)
Chunxiao Hu (1)
Haifeng Han (1)
Mingxia Li (3)
Sanyuan Hu (1) - 关键词：Bariatric surgery ; Sleeve gastrectomy ; Ghrelin ; Glucagon ; like peptide ; 1 ; Peptide YY ; Goto–Kakizaki rat
- 刊名：Surgical Endoscopy
- 出版年：2014
- 出版时间：March 2014
- 年：2014
- 卷：28
- 期：3
- 页码：1010-1018
- 全文大小：733 KB
- 参考文献：1. Himpens J, Dobbeleir J, Peeters G (2010) Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 252:319-24 CrossRef
2. Vidal J, Ibarzabal A, Romero F, Delgado S, Momblan D, Flores L, Lacy A (2008) Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 18:1077-082 CrossRef
3. Chambers AP, Stefater MA, Wilson-Perez HE, Jessen L, Sisley S, Ryan KK, Gaitonde S, Sorrell JE, Toure M, Berger J, D’Alessio DA, Sandoval DA, Seeley RJ, Woods SC (2011) Similar effects of Roux-en-Y gastric bypass and vertical sleeve gastrectomy on glucose regulation in rats. Physiol Behav 105:120-23 CrossRef
4. Karra E, Yousseif A, Batterham RL (2010) Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery. Trends Endocrinol Metab 21:337-44 CrossRef
5. Ahn SM, Pomp A, Rubino F (2010) Metabolic surgery for type 2 diabetes. Ann N Y Acad Sci 1212:E37–E45 CrossRef
6. Rubino F, R’Bibo SL, del Genio F, Mazumdar M, McGraw TE (2010) Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol 6:102-09 CrossRef
7. Pereferrer FS, Gonzalez MH, Rovira AF, Blasco SB, Rivas AM, del Castillo Dejardin D (2008) Influence of sleeve gastrectomy on several experimental models of obesity: metabolic and hormonal implications. Obes Surg 18:97-08 CrossRef
8. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK (2008) Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 247:401-07 CrossRef
9. Bohdjalian A, Langer FB, Shakeri-Leidenmuhler S, Gfrerer L, Ludvik B, Zacherl J, Prager G (2010) Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg 20:535-40 CrossRef
10. Basso N, Capoccia D, Rizzello M, Abbatini F, Mariani P, Maglio C, Coccia F, Borgonuovo G, De Luca ML, Asprino R, Alessandri G, Casella G, Leonetti F (2011) First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72?h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis. Surg Endosc 25:3540-550 CrossRef
11. Pech N, Meyer F, Lippert H, Manger T, Stroh C (2012) Complications and nutrient deficiencies two years after sleeve gastrectomy. BMC Surg 12:13 CrossRef
12. Li F, Zhang G, Liang J, Ding X, Cheng Z, Hu S (2009) Sleeve gastrectomy provides a better control of diabetes by decreasing ghrelin in the diabetic Goto–Kakizaki rats. J Gastrointest Surg 13:2302-308 CrossRef
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-19 CrossRef
14. Boza C, Salinas J, Salgado N, Perez G, Raddatz A, Funke R, Pimentel F, Ibanez L (2012) Laparoscopic sleeve gastrectomy as a stand-alone procedure for morbid obesity: report of 1,000 cases and 3-year follow-up. Obes Surg 22:866-71 CrossRef
15. Gagner M, Gumbs AA, Milone L, Yung E, Goldenberg L, Pomp A (2008) Laparoscopic sleeve gastrectomy for the super-super-obese (body mass index >60?kg/m2. Surg Today 38:399-03 CrossRef
16. Abbatini F, Rizzello M, Casella G, Alessandri G, Capoccia D, Leonetti F, Basso N (2010) Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 24:1005-010 CrossRef
17. Shah PS, Todkar JS, Shah SS (2010) Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus. Surg Obes Relat Dis 6:138-41 CrossRef
18. Lee WJ, Ser KH, Chong K, Lee YC, Chen SC, Tsou JJ, Chen JC, Chen CM (2010) Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery 147:664-69 CrossRef
19. Pournaras DJ, Osborne A, Hawkins SC, Vincent RP, Mahon D, Ewings P, Ghatei MA, Bloom SR, Welbourn R, le Roux CW (2010) Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2?year outcomes. Ann Surg 252:966-71 CrossRef
20. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992 CrossRef
21. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M (2000) Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141:4255-261
22. Couce ME, Cottam D, Esplen J, Schauer P, Burguera B (2006) Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer. Obes Surg 16:870-78 CrossRef
23. Cummings DE, Shannon MH (2003) Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? J Clin Endocrinol Metab 88:2999-002 CrossRef
24. Carrasco F, Rojas P, Csendes A, Codoceo J, Inostroza J, Basfi-fer K, Papapietro K, Watkins G, Rojas J, Ruz M (2012) Changes in ghrelin concentrations one year after resective and non-resective gastric bypass: associations with weight loss and energy and macronutrient intakes. Nutrition 28:757-61 CrossRef
25. Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB (2004) Ghrelin: a hormone with multiple functions. Front Neuroendocrinol 25:27-8 CrossRef
26. Tymitz K, Engel A, McDonough S, Hendy MP, Kerlakian G (2011) Changes in ghrelin levels following bariatric surgery: review of the literature. Obes Surg 21:125-30 CrossRef
27. Dezaki K, Sone H, Yada T (2008) Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. Pharmacol Ther 118:239-49 CrossRef
28. Romero F, Nicolau J, Flores L, Casamitjana R, Ibarzabal A, Lacy A, Vidal J (2012) Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc 26:2231-239 CrossRef
29. Gaitonde S, Kohli R, Seeley R (2012) The role of the gut hormone GLP-1 in the metabolic improvements caused by ileal transposition. J Surg Res 178:33-9 CrossRef
30. Mingrone G (2008) Role of the incretin system in the remission of type 2 diabetes following bariatric surgery. Nutr Metab Cardiovasc Dis 18:574-79 CrossRef
31. Patriti A, Facchiano E, Annetti C, Aisa MC, Galli F, Fanelli C, Donini A (2005) Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg 15:1258-264 CrossRef
32. Wang TT, Hu SY, Gao HD, Zhang GY, Liu CZ, Feng JB, Frezza EE (2008) Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg 247:968-75 CrossRef
33. Masuda T, Ohta M, Hirashita T, Kawano Y, Eguchi H, Yada K, Iwashita Y, Kitano S (2011) A comparative study of gastric banding and sleeve gastrectomy in an obese diabetic rat model. Obes Surg 21:1774-780 CrossRef
34. Peterli R, Steinert RE, Woelnerhanssen B, Peters T, Christoffel-Courtin C, Gass M, Kern B, von Fluee M, Beglinger C (2012) Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg 22:740-48 CrossRef
35. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR (2002) Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418:650-54 CrossRef
36. Rizzello M, Abbatini F, Casella G, Alessandri G, Fantini A, Leonetti F, Basso N (2010) Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg 20:50-5 CrossRef
37. van den Hoek AM, Heijboer AC, Voshol PJ, Havekes LM, Romijn JA, Corssmit EP, Pijl H (2007) Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice. Am J Physiol Endocrinol Metab 292:E238–E245 CrossRef
38. Konturek SJ, Pepera J, Zabielski K, Konturek PC, Pawlik T, Szlachcic A, Hahn EG (2003) Brain-gut axis in pancreatic secretion and appetite control. J Physiol Pharmacol 54:293-17
39. Aguirre V, Stylopoulos N, Grinbaum R, Kaplan LM (2008) An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity. Obesity (Silver Spring) 12:2585-592 CrossRef - 作者单位：Dong Sun (1)
Shaozhuang Liu (1)
Guangyong Zhang (1)
Punsiri Colonne (2)
Chunxiao Hu (1)
Haifeng Han (1)
Mingxia Li (3)
Sanyuan Hu (1)
1. Department of General Surgery, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, People’s Republic of China
2. Department of Anesthesiology, University of Illinois at Chicago, Chicago, IL, 60612, USA
3. Experimental Center, School of Chemistry and Chemical Engineering of Shandong University, Jinan, 250100, Shandong, People’s Republic of China - ISSN：1432-2218
文摘
Background Although weight loss has been implicated in anti-diabetic effects, sleeve gastrectomy (SG)-mediated anti-diabetic effects are induced through mechanisms beyond weight loss. Our aim was to investigate whether anti-diabetic effects can be achieved by surgically removing a smaller portion of the stomach instead of SG. Methods Male 11-week-old Goto–Kakizaki rats (N?=?50) were randomized into five groups: sub-sleeve gastrectomy (SSG, only the gastric fundus is removed), SG, sham-operated SSG, sham-operated SG, and control. Body weight, food intake, hormone secretion, and glucose metabolism were measured up to 24?weeks after surgery. Results The data showed that (i) both SSG and SG surgeries significantly improved glucose homeostasis, with lower ghrelin levels and higher post-prandial glucagon-like peptide 1, peptide YY, and insulin levels; (ii) SG, but not SSG, produced sustained weight loss and significant reduction of food intake; and (iii) SG induced better long-term diabetic improvement than SSG. Conclusions The SSG that only removed the gastric fundus exhibited significant diabetic improvement without weight loss, but did not induce long-term diabetic improvement comparable to that of SG. Our study helps to understand the role of hormones and weight loss in maintaining long-term diabetes improvement after SG.